Manulife US REIT Suspends Distributions to Investors – Goodman & Nekvasil, P.A., May Recover Investor Losses
Manulife US REIT suspends distributions to shareholders. The net asset value per unit is $0.40 as at the end of July 2023. Manulife’s August press release said the drop is, “mainly due to its fair value loss on investment properties. .
Goodman & Nekvasil, P.A. is investigating broker-dealer firms and financial advisors who made recommendations to their clients to make substantial investments in Manulife US REIT.
Manulife US REIT Investigation
Manulife US REIT Losses
The company’s financial data revealed that the manager is currently in negotiations with lenders to address the breach of financial covenant and bolster liquidity. It continues to pursue a disposition mandate to sell assets to reduce indebtedness and fund capex, while evaluating potential strategic options to recapitalize the balance sheet of the REIT.
Goodman & Nekvasil, P.A., is investigating broker dealers who may have unsuitably recommended Manulife US REIT to its clients.
REITs are risky and complicated investments. Goodman & Nekvasil, P.A., a Clearwater, Florida, law firm with a national practice representing victimized investors, continues to investigate brokerage firms that placed elderly retirees and other conservative investors in high-risk investments such as Manulife US REIT.
Goodman & Nekvasil, P.A., has filed numerous cases against brokerage firms selling high-risk investments and has recovered more than $400 million dollars on behalf of victimized investors. We allege in these cases that these investment recommendations were unsuitable for our clients in view of their financial situation, needs and investment objectives.
There is no charge for an evaluation of your case. We handle our cases on a contingency fee basis. This means that unless we recover money for you, we charge no attorney’s fee.
If you incurred losses on your investment and would like your case evaluated by a securities attorney, please contact us.
Some of the information in this blog post was obtained from published press releases. If you believe this information was reported incorrectly, please contact our firm: 1-800-500-4442.